- Home
- PTCT vs SLG Comparison
PTCT vs SLG Comparison
Compare PTCT & SLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTCT
- SLG
- Stock Information
- Founded
- PTCT 1998
- SLG 1980
- Country
- PTCT United States
- SLG United States
- Employees
- PTCT N/A
- SLG N/A
- Industry
- PTCT Biotechnology: Pharmaceutical Preparations
- SLG Real Estate Investment Trusts
- Sector
- PTCT Health Care
- SLG Real Estate
- Exchange
- PTCT Nasdaq
- SLG Nasdaq
- Market Cap
- PTCT 5.3B
- SLG 4.0B
- IPO Year
- PTCT 2013
- SLG 1997
- Fundamental
- Price
- PTCT $75.61
- SLG $47.92
- Analyst Decision
- PTCT Buy
- SLG Buy
- Analyst Count
- PTCT 17
- SLG 15
- Target Price
- PTCT $73.24
- SLG $63.00
- AVG Volume (30 Days)
- PTCT 1.1M
- SLG 1.2M
- Earning Date
- PTCT 11-04-2025
- SLG 10-15-2025
- Dividend Yield
- PTCT N/A
- SLG 6.39%
- EPS Growth
- PTCT N/A
- SLG N/A
- EPS
- PTCT 8.94
- SLG N/A
- Revenue
- PTCT $1,779,150,000.00
- SLG $661,814,000.00
- Revenue This Year
- PTCT $119.02
- SLG N/A
- Revenue Next Year
- PTCT N/A
- SLG $9.79
- P/E Ratio
- PTCT $8.37
- SLG N/A
- Revenue Growth
- PTCT 97.54
- SLG N/A
- 52 Week Low
- PTCT $35.95
- SLG $45.15
- 52 Week High
- PTCT $75.82
- SLG $80.90
- Technical
- Relative Strength Index (RSI)
- PTCT 80.05
- SLG 31.32
- Support Level
- PTCT $69.23
- SLG $49.20
- Resistance Level
- PTCT $73.98
- SLG $51.25
- Average True Range (ATR)
- PTCT 2.67
- SLG 1.65
- MACD
- PTCT 0.41
- SLG -0.09
- Stochastic Oscillator
- PTCT 91.20
- SLG 5.07
About PTCT PTC Therapeutics Inc.
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.
About SLG SL Green Realty Corp
SL Green Realty is one of the largest Manhattan property owners and landlords, with interest in around 32 million square feet of wholly owned and joint-venture office space. The company has additional property exposure through its limited portfolio of well-located retail space. It operates as a real estate investment trust.